000181493 001__ 181493
000181493 005__ 20240229145648.0
000181493 0247_ $$2doi$$a10.3390/nu14163282
000181493 0247_ $$2pmid$$apmid:36014788
000181493 0247_ $$2altmetric$$aaltmetric:133987264
000181493 037__ $$aDKFZ-2022-02028
000181493 041__ $$aEnglish
000181493 082__ $$a610
000181493 1001_ $$0P:(DE-He78)e71d98af5fac4f81eb58e74b7b3095c2$$aZhu, Anna$$b0$$eFirst author$$udkfz
000181493 245__ $$aConsistent Inverse Associations of Total, 'Bioavailable', Free, and 'Non-Bioavailable' Vitamin D with Incidence of Diabetes among Older Adults with Lower Baseline HbA1c (≤6%) Levels.
000181493 260__ $$aBasel$$bMDPI$$c2022
000181493 3367_ $$2DRIVER$$aarticle
000181493 3367_ $$2DataCite$$aOutput Types/Journal article
000181493 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1669821420_18877
000181493 3367_ $$2BibTeX$$aARTICLE
000181493 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181493 3367_ $$00$$2EndNote$$aJournal Article
000181493 500__ $$a#EA:C070#LA:C070#
000181493 520__ $$aSerum 25-hydroxyvitamin (25(OH)D) levels are inversely associated with risk of diabetes. The 'free hormone hypothesis' suggests potential effects to be mainly related to concentrations of 'bioavailable' and free rather than total 25(OH)D. We assessed associations of serum concentrations of vitamin D-binding protein (VDBP), as well as total 'bioavailable', complementary 'non-bioavailable', and free 25(OH)D, with the risk of developing diabetes among non-diabetic older adults in a large population-based cohort study in Germany.We included 4841 non-diabetic older adults aged 50-75 years at the baseline exam from the ESTHER cohort conducted in Saarland, Germany, in 2001-2002. Concentrations of 'bioavailable' and free 25(OH)D were derived from serum concentrations of VDBP, total 25(OH)D, and albumin. Incidence of diabetes was ascertained during up to 14 years of follow-up. Associations were quantified by multivariable Cox proportional hazards regression models with comprehensive confounder adjustment.During a median follow-up of 10.6 years, 837 non-diabetic participants developed diabetes. We observed similar inverse associations with developing diabetes for VDBP (hazard ratio (HR) for lowest versus highest quintile: 1.37, 95% confidence interval (CI): 1.09, 1.72), total 25(OH)D (HR: 1.31, 95% CI: 1.03, 1.66), and 'non-bioavailable' 25(OH)D (HR: 1.30, 95% CI: 1.02, 1.65). Associations were smaller and statistically insignificant for 'bioavailable' and free 25(OH)D. However, associations of total 'non-bioavailable', 'bioavailable', and free 25(OH)D with incidence of diabetes were much stronger among, and essentially restricted to, participants with lower baseline HbA1c (≤6%) levels.This large prospective cohort study of older Caucasian adults, in agreement with results from randomized trials and Mendelian randomization studies, supports a protective effect of vitamin D against development of diabetes. The 'free hormone theory' may not be relevant in this context. However, our results underline the importance of adequate vitamin D status among those who have not yet shown any sign of impaired glucose tolerance.
000181493 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000181493 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181493 650_7 $$2Other$$abioavailable 25(OH)D
000181493 650_7 $$2Other$$afree 25(OH)D
000181493 650_7 $$2Other$$atype 2 diabetes
000181493 650_7 $$2Other$$avitamin D
000181493 650_7 $$2Other$$avitamin D-binding protein
000181493 7001_ $$0P:(DE-He78)a1d1b323625dcfa155b477a646cbda52$$aKuznia, Sabine$$b1$$udkfz
000181493 7001_ $$0P:(DE-He78)20dc4ad11ff465acf5b99f1e679e10b7$$aNiedermaier, Tobias$$b2$$udkfz
000181493 7001_ $$aHolleczek, Bernd$$b3
000181493 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b4$$udkfz
000181493 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author$$udkfz
000181493 773__ $$0PERI:(DE-600)2518386-2$$a10.3390/nu14163282$$gVol. 14, no. 16, p. 3282 -$$n16$$p3282$$tNutrients$$v14$$x2072-6643$$y2022
000181493 909CO $$ooai:inrepo02.dkfz.de:181493$$pVDB
000181493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e71d98af5fac4f81eb58e74b7b3095c2$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000181493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1d1b323625dcfa155b477a646cbda52$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000181493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)20dc4ad11ff465acf5b99f1e679e10b7$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000181493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000181493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000181493 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000181493 9141_ $$y2022
000181493 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000181493 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000181493 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000181493 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000181493 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000181493 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000181493 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-09
000181493 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-09
000181493 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-08-27T10:32:17Z
000181493 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-08-27T10:32:17Z
000181493 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2022-08-27T10:32:17Z
000181493 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-09
000181493 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-09
000181493 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-09
000181493 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000181493 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000181493 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000181493 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000181493 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000181493 980__ $$ajournal
000181493 980__ $$aVDB
000181493 980__ $$aI:(DE-He78)C070-20160331
000181493 980__ $$aI:(DE-He78)C120-20160331
000181493 980__ $$aI:(DE-He78)HD01-20160331
000181493 980__ $$aUNRESTRICTED